Temasek Buys Shares of Gilead Sciences, China’s 21Vianet
This article is for subscribers only.
Temasek Holdings Pte, Singapore’s state-owned investment firm, added shares of pharmaceutical maker Gilead Sciences Inc. and Chinese Web data company 21Vianet Group Inc. in the fourth quarter.
Temasek, directly or through its units, bought 5.65 million shares of Foster City, California-based Gilead valued at $424 million as of Dec. 31 and 6.67 million American depositary receipts of Beijing-based 21Vianet worth $157 million, according to a filing today with the U.S. Securities and Exchange Commission.